Humacyte Phase 3 V012 results accepted for ASN Kidney Week presentation
Results for the ATEV trial in women requiring hemodialysis access were accepted for a late-breaking session at ASN Kidney Week 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.